Wells Fargo & Company Lowers Mettler-Toledo International (NYSE:MTD) Price Target to $1,350.00

Mettler-Toledo International (NYSE:MTD) had its price objective decreased by Wells Fargo & Company from $1,400.00 to $1,350.00 in a research note released on Monday morning,Benzinga reports. Wells Fargo & Company currently has an equal weight rating on the medical instruments supplier’s stock.

MTD has been the subject of several other reports. JPMorgan Chase & Co. raised their target price on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a “neutral” rating in a research report on Monday, August 5th. Evercore ISI lifted their price objective on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an “in-line” rating in a research report on Tuesday, October 1st. Stifel Nicolaus upped their target price on Mettler-Toledo International from $1,510.00 to $1,550.00 and gave the stock a “buy” rating in a report on Monday, August 5th. Finally, Robert W. Baird lowered their target price on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a research note on Monday. Two research analysts have rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, Mettler-Toledo International presently has a consensus rating of “Hold” and a consensus target price of $1,338.75.

Mettler-Toledo International Stock Performance

Shares of NYSE MTD traded up $15.03 during trading hours on Monday, hitting $1,265.10. The company’s stock had a trading volume of 7,308 shares, compared to its average volume of 133,577. The business has a 50-day simple moving average of $1,394.23 and a 200-day simple moving average of $1,402.64. The stock has a market cap of $26.84 billion, a price-to-earnings ratio of 33.70, a P/E/G ratio of 3.83 and a beta of 1.16. Mettler-Toledo International has a 12 month low of $1,015.29 and a 12 month high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 532.25% and a net margin of 21.15%. The firm had revenue of $954.54 million for the quarter, compared to analysts’ expectations of $941.93 million. On average, equities research analysts forecast that Mettler-Toledo International will post 40.34 EPS for the current year.

Insider Buying and Selling

In other news, insider Christian Magloth sold 1,000 shares of the firm’s stock in a transaction dated Thursday, August 15th. The shares were sold at an average price of $1,422.97, for a total transaction of $1,422,970.00. Following the sale, the insider now owns 734 shares of the company’s stock, valued at $1,044,459.98. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 1.94% of the stock is owned by corporate insiders.

Institutional Trading of Mettler-Toledo International

Large investors have recently modified their holdings of the company. EverSource Wealth Advisors LLC grew its stake in shares of Mettler-Toledo International by 8.0% during the 1st quarter. EverSource Wealth Advisors LLC now owns 95 shares of the medical instruments supplier’s stock valued at $117,000 after purchasing an additional 7 shares during the period. UMB Bank n.a. increased its holdings in Mettler-Toledo International by 6.6% during the second quarter. UMB Bank n.a. now owns 113 shares of the medical instruments supplier’s stock valued at $158,000 after buying an additional 7 shares during the last quarter. Bellevue Group AG raised its position in Mettler-Toledo International by 32.0% in the first quarter. Bellevue Group AG now owns 33 shares of the medical instruments supplier’s stock worth $44,000 after acquiring an additional 8 shares during the period. Massmutual Trust Co. FSB ADV boosted its stake in shares of Mettler-Toledo International by 7.2% during the 2nd quarter. Massmutual Trust Co. FSB ADV now owns 119 shares of the medical instruments supplier’s stock worth $166,000 after acquiring an additional 8 shares during the last quarter. Finally, DT Investment Partners LLC grew its position in shares of Mettler-Toledo International by 13.3% during the 3rd quarter. DT Investment Partners LLC now owns 68 shares of the medical instruments supplier’s stock valued at $102,000 after acquiring an additional 8 shares during the period. Institutional investors own 95.07% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.